LobbyingDiagnostic Test Work Group lobbying by quarter
Diagnostic Test Work Group's latest lobbying report covers Q4 2023, at $20K. Its first report covers Q1 2022; the issues it reports most are Health Issues.
Diagnostic Test Work Group
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2022 | $80K | 1 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $80K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$220K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)6 reports
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
- Health & Human Services, Dept of (HHS)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Leavitt Partners | $220K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DAVID LEE | Staff Assistant - Senate; Legislative Correspondent - Senate | Q1 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/01/10for Q4 2023 | Leavitt Partners | $20K |
| 23/10/25for Q1 2022 | Leavitt Partners | $80K |
| 23/10/25for Q1 2023 | Leavitt Partners | $10K |
| 23/10/20for Q3 2023 | Leavitt Partners | $10K |
| 23/07/12for Q2 2023 | Leavitt Partners | $20K |
| 23/04/19for Q1 2023 | Leavitt Partners | $10K |
| 23/01/17for Q4 2022 | Leavitt Partners | $80K |